- Home
- HOWL vs LODE Comparison
HOWL vs LODE Comparison
Compare HOWL & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- LODE
- Stock Information
- Founded
- HOWL 2017
- LODE 2008
- Country
- HOWL United States
- LODE United States
- Employees
- HOWL N/A
- LODE N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- LODE Major Chemicals
- Sector
- HOWL Health Care
- LODE Industrials
- Exchange
- HOWL Nasdaq
- LODE Nasdaq
- Market Cap
- HOWL 62.4M
- LODE 61.6M
- IPO Year
- HOWL 2021
- LODE N/A
- Fundamental
- Price
- HOWL $1.23
- LODE $2.49
- Analyst Decision
- HOWL Strong Buy
- LODE Buy
- Analyst Count
- HOWL 3
- LODE 1
- Target Price
- HOWL $9.00
- LODE $26.00
- AVG Volume (30 Days)
- HOWL 241.7K
- LODE 470.8K
- Earning Date
- HOWL 03-11-2025
- LODE 03-06-2025
- Dividend Yield
- HOWL N/A
- LODE N/A
- EPS Growth
- HOWL N/A
- LODE N/A
- EPS
- HOWL N/A
- LODE N/A
- Revenue
- HOWL $1,885,000.00
- LODE $3,016,163.00
- Revenue This Year
- HOWL $36.45
- LODE $69.41
- Revenue Next Year
- HOWL $296.58
- LODE $64.66
- P/E Ratio
- HOWL N/A
- LODE N/A
- Revenue Growth
- HOWL N/A
- LODE 136.66
- 52 Week Low
- HOWL $1.03
- LODE $1.30
- 52 Week High
- HOWL $6.89
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- HOWL 44.53
- LODE 36.95
- Support Level
- HOWL $1.18
- LODE $2.32
- Resistance Level
- HOWL $1.29
- LODE $2.99
- Average True Range (ATR)
- HOWL 0.10
- LODE 0.32
- MACD
- HOWL 0.00
- LODE 0.01
- Stochastic Oscillator
- HOWL 56.10
- LODE 18.78
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.